Akebia Therapeutics
AKBA
#7282
Rank
HK$2.97 B
Marketcap
HK$13.63
Share price
-2.23%
Change (1 day)
10.30%
Change (1 year)

Revenue for Akebia Therapeutics (AKBA)

Revenue in 2024 (TTM): HK$1.32 Billion

According to Akebia Therapeutics's latest financial reports the company's current revenue (TTM ) is HK$1.32 Billion. In 2023 the company made a revenue of HK$1.52 Billion a decrease over the revenue in the year 2022 that were of HK$2.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Akebia Therapeutics from 2013 to 2024

201620192022$0.5B$1B$1.5B$2B$2.5B$3B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) HK$1.32 B-12.77%
2023 HK$1.52 B-33.37%
2022 HK$2.28 B36.97%
2021 HK$1.66 B-27.25%
2020 HK$2.28 B-12.26%
2019 HK$2.60 B60.38%
2018 HK$1.62 B16.99%
2017 HK$1.39 B11582.37%
2016 HK$11.9 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$253.35 B 19,051.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$388.89 B 29,297.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$682.91 B 51,522.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.72 B-45.17%๐Ÿ‡บ๐Ÿ‡ธ USA